IMPROVING REGULATORY TRANSPARENCY FOR NEW MEDICAL THERAPIES ACT
Amendments
Enact (H.R. 639), S7494 [26OC], H8212 [16NO]
Bills and resolutions
Enact (see S. 481), S982 [12FE]
Cost Estimates
Provisions (H.R. 639): CBO, H1641 [16MR]
Letters
Provisions: Representative Goodlatte, Committee on the Judiciary (House), H1640 [16MR]
——— Representative Upton, Committee on Energy and Commerce (House), H1640 [16MR]
Remarks in House
Enact (H.R. 639), H1638–H1641 [16MR]
——— Senate amendment, H8212, H8213 [16NO]
Remarks in Senate
Enact (H.R. 639), S7495 [26OC]
Reports filed
Provisions: Committee on Energy and Commerce (House) (H.R. 639) (H. Rept. 114–41), H1660 [16MR]
——— Committee on Health, Education, Labor, and Pensions (Senate) (S. 481), S7101 [1OC]
Texts of